Effects of Integrase Inhibitor-Based ART on the NLRP3 Inflammasome Among ART-Naive People With HIV

Abstract
The NOD-like receptor protein family pyrin domain containing 3 (NLRP3) inflammasome, activated in the setting of HIV, contributes to pro-atherogenic inflammation. Among antriretroviral therapy-naive people with HIV (vs controls), levels of caspase-1-a key component of the NLRP3 inflammasome-were significantly increased. Six months of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate significantly decreased caspase-1 levels in association with CD4+/CD8+ ratio recovery.
Funding Information
  • National Institutes of Health (R01HL141132)
  • National Heart, Lung, and Blood Institute (1K23HL147799-01)
  • American Heart Association
  • Harold Amos Medical Research Faculty Development Program
  • Robert Wood Johnson Foundation
  • Nutrition Obesity Research Center at Harvard (DK040561)
  • National Center for Research Resources (8 UL 1TR000170, 1 UL 1TR001102)

This publication has 22 references indexed in Scilit: